SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001209191-17-007070
Filing Date
2017-02-02
Accepted
2017-02-02 16:10:36
Documents
1
Period of Report
2017-01-31

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 3361
  Complete submission text file 0001209191-17-007070.txt   4711
Mailing Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878
Business Address 20 FIRSTFIELD ROAD GAITHERSBURG MD 20878 240-268-2000
NOVAVAX INC (Issuer) CIK: 0001000694 (see all company filings)

IRS No.: 222816046 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2836 Biological Products, (No Diagnostic Substances)

Mailing Address C/O CANCER VAX CORP 2110 RUTHERFORD ROAD CARLSBAD CA 92008
Business Address
PHILLIPS BARCLAY A (Reporting) CIK: 0001265801 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-26770 | Film No.: 17568363